Yu ST - Search Results

1

Selperctinib as neoadjuvant therapy for RET-altered papillary thyroid carcinoma: Two case reports.

Yu ST, Huang D, Xiong C, Xie R, Yu J. Yu ST, et al. Oral Oncol. 2024 Dec 17;161:107140. doi: 10.1016/j.oraloncology.2024.107140. Online ahead of print. Oral Oncol. 2024. PMID: 39693900

2

Minimally Invasive Video-Assisted Surgical Management for Parapharyngeal Metastases From Papillary Thyroid Carcinoma: A Case Series Report.

Yu ST, Chen WZ, Xu DB, Xie R, Zhou T, Yu JC. Yu ST, et al. Among authors: yu jc. Front Oncol. 2019 Nov 22;9:1226. doi: 10.3389/fonc.2019.01226. eCollection 2019. Front Oncol. 2019. PMID: 31824838 Free PMC article.

3

SYTL5 Promotes Papillary Thyroid Carcinoma Progression by Enhancing Activation of the NF-κB Signaling Pathway.

Huang D, Zeng Y, Deng HY, Fu BD, Ke Y, Luo JY, Yu JC, Yu ST. Huang D, et al. Among authors: yu jc, yu st. Endocrinology. 2022 Nov 14;164(1):bqac187. doi: 10.1210/endocr/bqac187. Endocrinology. 2022. PMID: 36378561

4

Preoperative albumin/globulin ratio has predictive value for patients with laryngeal squamous cell carcinoma.

Chen WZ, Yu ST, Xie R, Lv YX, Xu DB, Yu JC. Chen WZ, et al. Among authors: yu jc, yu st. Oncotarget. 2017 Jul 18;8(29):48240-48247. doi: 10.18632/oncotarget.18443. Oncotarget. 2017. PMID: 28654895 Free PMC article.

5

Pretreatment BMI Is Associated with Aggressive Clinicopathological Features of Papillary Thyroid Carcinoma: A Multicenter Study.

Yu ST, Chen W, Cai Q, Liang F, Xu D, Han P, Yu J, Huang X. Yu ST, et al. Among authors: yu j. Int J Endocrinol. 2017;2017:5841942. doi: 10.1155/2017/5841942. Epub 2017 Sep 20. Int J Endocrinol. 2017. PMID: 29085428 Free PMC article.

6

Pretreatment albumin globulin ratio has a superior prognostic value in laryngeal squamous cell carcinoma patients: a comparison study.

Zhou T, Yu ST, Chen WZ, Xie R, Yu JC. Zhou T, et al. Among authors: yu jc, yu st. J Cancer. 2019 Jan 1;10(3):594-601. doi: 10.7150/jca.28817. eCollection 2019. J Cancer. 2019. PMID: 30719156 Free PMC article.

7

Lymph node yield in the initial central neck dissection (CND) associated with the risk of recurrence in papillary thyroid cancer: A reoperative CND cohort study.

Yu ST, Ge JN, Sun BH, Wei ZG, Xiao ZZ, Zhang ZC, Chen WS, Li TT, Lei ST. Yu ST, et al. Oral Oncol. 2021 Dec;123:105567. doi: 10.1016/j.oraloncology.2021.105567. Epub 2021 Oct 25. Oral Oncol. 2021. PMID: 34710736

8

Letter to the Editor regarding, "Total thyroidectomy versus lobectomy for intermediate-risk papillary thyroid carcinoma: A single-institution matched-pair analysis".

Yu ST, Xiao ZZ. Yu ST, et al. Oral Oncol. 2019 Apr;91:132-133. doi: 10.1016/j.oraloncology.2019.02.007. Epub 2019 Feb 14. Oral Oncol. 2019. PMID: 30773348 No abstract available.

9

Lymph node metastasis in suprasternal space in pathological node-positive papillary thyroid carcinoma.

Yu ST, Ge JN, Sun BH, Wei ZG, Lei ST. Yu ST, et al. Eur J Surg Oncol. 2019 Nov;45(11):2086-2089. doi: 10.1016/j.ejso.2019.07.034. Epub 2019 Aug 1. Eur J Surg Oncol. 2019. PMID: 31395292

10

Primary squamous cell carcinoma (PSCC) of the thyroid: a case report and review of the literature.

Sun BH, Yu ST, Ge JN, Lei ST. Sun BH, et al. Among authors: yu st. Gland Surg. 2020 Apr;9(2):474-477. doi: 10.21037/gs.2020.02.18. Gland Surg. 2020. PMID: 32420277 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

138 results

Search Page

Filters